For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Altimmune, Inc.

USPTO Granted Patents = 12

CIPO Patents = 11

EPO Patents = 3

Forward Citations = 17

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

De-Chu C Tang (6 out of 11 patents)

Kent R Van Kampen (3 out of 7 patents)

De-chu C Tang (3 out of 3 patents)

4. M Scot Roberts (2 out of 2 patents)

5. Haroldo E Toro (2 out of 5 patents)

6. Aime K Johnson (1 out of 1 patent)

7. Prachi Sangle (1 out of 1 patent)

8. Allan E David (1 out of 2 patents)

9. Henry J Baker (1 out of 8 patents)

10. Bertrand Victor Gilbert Georges (1 out of 8 patents)

11. John J Nestor (1 out of 13 patents)

12. Chun-Ming Huang (1 out of 2 patents)

13. JianFeng Zhang (1 out of 1 patent)

14. Harold Toro (0 patent)

12 patents: Sort by Forward Citations

1. 11541028 - Peptide pharmaceuticals for treatment of NASH and other disorders (2023-01-03),

2. 11395802 - Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof (2022-07-26),

3. 11382968 - Coronavirus immunogenic compositions and uses thereof (2022-07-12),

4. 11141477 - Rapid and prolonged immunologic-therapeutic (2021-10-12),

5. 11040100 - Rapid and prolonged immunogic therapeutic (2021-06-22),

6. 11040099 - Rapid and prolonged immunologic therapeutic (2021-06-22),

7. 10744195 - Immunization of avians by administration of non-replicating vectored vaccines (2020-08-18),

8. 10183069 - Rapid and prolonged immunologic-therapeutic (2019-01-22),

9. 9968667 - Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax (2018-05-15),

10. 9855328 - Immunization of avians by administration of non-replicating vectored vaccines (2018-01-02),

11. 9605275 - Rapid and prolonged immunologic-therapeutic (2017-03-28),

12. 9175310 - Rapid and prolonged immunologic-therapeutic (2015-11-03),

Altimmune, Inc. is a clinical-stage biopharmaceutical company that focuses on developing and commercializing novel immunotherapeutic products for the treatment of infectious diseases. The company's product pipeline includes vaccine candidates for respiratory and liver diseases, as well as treatments for immune-mediated disorders. With a dedication to innovative research and development, Altimmune aims to improve patient outcomes and address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

12 Patents

#38 in Gaithersburg, MD

#333 in Maryland

#24,779 in US

#46,665 in the World

Gaithersburg, MD, United States of America

Altimmune, Inc.

Forward Citations = 17

14 inventors:

De-Chu C Tang (6 out of 11 patents)

Kent R Van Kampen (3 out of 7 patents)

De-chu C Tang (3 out of 3 patents)

4. M Scot Roberts (2 out of 2 patents)

5. Haroldo E Toro (2 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…